Health
Synthetic Mini-Antibody Identified to Combat COVID-19 – SciTechDaily
The ability of SARS-CoV-2 to infect cells depends on interactions between the viral spike protein and the human cell surface protein ACE2. To enable the virus to…
SARS-CoV-2’s ability to infect cells relies on interactions between the viral spike protein (magenta) and the protein ACE2 (blue), which is present on the surface of human cells. These interactions can be disrupted by sybodies (black) — synthetic mini-antibodies similar to those produced by camels and llamas. Credit: Rayne Zaayman-Gallant/EMBL
The ability of SARS-CoV-2 to infect cells depends on interactions between the viral spike protein and the human cell surface protein ACE2. To enable the virus…
-
General17 hours agoStar Wars’ fascist dystopia has never felt closer than in new season of Andor
-
General20 hours agoCoalition to chart path forward as family feud cooled
-
Noosa News20 hours agoInterest rates: Why we will keep paying the same repayments
-
Noosa News17 hours agoQueensland Premier David Crisafulli keeps clear of Coalition chaos in Canberra